Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intraop Medical Corp.

www.intraopmedical.com

Latest From Intraop Medical Corp.

ASBS 2010: Economy, Rise in Mastectomies Temper Minimally Invasive Advancements in Breast Care

Surgeons attending the 11th annual meeting of the American Society of Breast Surgeons were perplexed by the reversal of the trend away from mastectomy and toward breast-conserving therapies. Advanced breast-conserving products were presented at the meeting; but with lowered revenue expectations that can ultimately be attributed to the economic woes of the past couple of years. High unemployment and the lack of health care coverage have prompted many women to delay or forego their yearly mammogram, and as a result, the numbers of biopsies, surgeries, and radiation therapy procedures have declined as well.
Medical Device

Frontiers in Breast Cancer Research, Part II: Developments in Partial Breast Irradiation and Tumor Ablation

As the use of breast conserving lumpectomy expands as a treatment for early-stage breast cancer, interest has surged in alternatives to whole breast irradiation. Follow-on radiation treatment is crucial to the success of this therapy, but a significant number of women are either unable or unwilling to undergo the typical treatment course involving five to seven weeks of daily radiation therapy. The device industry is responding with technologies aimed at delivering post-lumpectomy radiation therapy in a more convenient, potentially safer way.
Medical Device

Breast Cancer: The Evolution in Breast Biopsy, Surgery, and Brachytherapy

Advances in breast cancer screening are making earlier detection the norm, but biopsy devices are progressing as well. Emerging technologies, along with a number of new oncolytic drugs, will add add to the growing treatment armamentarium for breast cancer.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Intraop Medical Corp.
  • Senior Management
  • John Powers, CEO
    Jones Wink, Dir., Mktg. & Strategic Planning
    Dan Goer, PhD, Chief Scientist
  • Contact Info
  • Intraop Medical Corp.
    Phone: (408) 636-1020
    570 Del Rey Ave.
    Sunnyvale, CA 94085
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register